The Company wishes to announce that, with effect from 25 February 2025, Dr. William Pao was appointed as a non-executive member of the Company’s Board of Directors.
William is the co-founder and Chief Executive Officer of Revelio Therapeutics, Inc. Prior to Revelio, Dr. Pao held executive leadership positions in early- and late-stage R&D at F. Hoffmann-La Roche AG and Pfizer respectively. He is a member of the American Association for Cancer Research’s board of directors